Hege Kileng

Tromso, Norway

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study.

Prediction of long-term remission in patients following discontinuation of anti-TNF therapy in ulcerative colitis: a 10 year follow up study.

Journal: BMC gastroenterology

Published: May 02, 2022

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.

Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals.

Journal: JHEP reports : innovation in hepatology

Published: February 02, 2022

Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease.

Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease.

Journal: BMC gastroenterology

Published: January 31, 2022

Nobel prize for discovery of the hepatitis C virus.

Nobel prize for discovery of the hepatitis C virus.

Journal: Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke

Published: November 24, 2020

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway.

Effect of the baseline Y93H resistance-associated substitution in HCV genotype 3 for direct-acting antiviral treatment: real-life experience from a multicenter study in Sweden and Norway.

Journal: Scandinavian journal of gastroenterology

Published: August 20, 2019

Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.

Personalized treatment of hepatitis C genotype 1a in Norway and Sweden 2014-2016: a study of treatment outcome in patients with or without resistance-based DAA-therapy.

Journal: Scandinavian journal of gastroenterology

Published: November 06, 2018

Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.

Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.

Journal: BMC infectious diseases

Published: October 31, 2018

Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.

Future complications of chronic hepatitis C in a low-risk area: projections from the hepatitis c study in Northern Norway.

Journal: BMC infectious diseases

Published: January 06, 2017

Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.

Repeated intensified infliximab induction - results from an 11-year prospective study of ulcerative colitis using a novel treatment algorithm.

Journal: European journal of gastroenterology & hepatology

Published: October 18, 2016

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial.

Journal: Journal of hepatology

Published: June 07, 2016

Hepatitis C reinfection after sustained virological response.

Hepatitis C reinfection after sustained virological response.

Journal: Journal of hepatology

Published: August 31, 2015

Showing 1-11 of 11

Last Updated: 09/26/2026